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We investigated the clinical and molecular pattern of two young 
men affected by dysferlinopathy, that was first diagnosed as pol-
ymyositis. We show that their symptoms and clinical course al-
though progressive were peculiar, as well as their biopsy suggest-
ing a subsequent analysis of dysferlin protein by western blotting. 
Molecular analysis of dysferlin gene revealed pathogenetic muta-
tions in both cases. 
In such cases a screening with Western blot followed by DNA 
analysis of dysferlin gene is therefore recommended. We present 
a diagnostic algorythm for patients with suspected myositis but 
presenting signs of disease progression and poor response to 
steroids. 
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Introduction
LGMD2B or dysferlinopathy is an underdiagnosed 
clinical  entity  and  both  its  identification  and  its  treat-
ment approach are relevant for clinicians and geneticists. 
Muscle biopsy samples from patients with dysferlin defi-
ciency might be inflammatory (1) and ultrastructural ex-
amination shows numerous structural membrane defects 
(2), attributed to the fact that dysferlin deficient fibers fail 
to reseal plasmalemmal lesions occurring mainly during 
eccentric muscle contractions. We present two LGMD2B 
cases where an abrupt onset of weakness and markedly 
elevated CK levels and myalgia lead to a mistaken diag-
nosis of polymyositis and subsequent prolonged and in-
appropriate immunosuppressive therapy. Molecular and 
genetic studies are needed to obtain a definite diagnosis 
among cases with apparent refractory myositis or unex-
plained proximal muscular weakness with high CK, pain, 
myalgia and muscle swelling. 
Case report
Patient 1
During a field trip in Persia in 2006 we studied nu-
merous neuromuscular cases, and we investigated a 36 
year-old man that had onset of disease and muscle weak-
ness at age 18, and became rapidly wheelchair-bound 
for a proximo-distal myopathy since 22 years. Since 
his disease onset coincided with Iran-Iraq war and he 
presented muscle pain and fatigability with a high CK 
levels (5300 U/L), a toxic polymyositis was suspected. 
The patient was treated with steroids without benefit. 
The nature of the presumed toxic agents used during the 
Iran-Iraq war was not further defined. An EMG showed 
a myopathic pattern and short motor unit. A vastus lat-
eralis open muscle biopsy showed numerous lobulated 
fibers, type 1 fibres prevalence, degenerating fibers and 
macrophagic reaction (Fig. 1). We performed a detailed 
molecular analysis. Dysferlin protein analysis by west-
ern blotting showed absent protein. The screening of 
mutations in the dysferlin gene resulted in the iden-
tification  of  two  compound  heterozygous  mutations: 
one novel missense mutation in exon 38 (c.4024C > T, 
p.R1342W) and one single-base duplication in exon 26 
causing a frame-shifting (c.2706dupC, p.K903QfsX4). 
The effect of the novel missense mutation found was 
predicted to be “probably damaging” using Polyphen 
prediction software (http://genetics.bwh.harvard.edu). 
Patient 2 
A 14 year-old boy presented burning sensation in his 
legs and during a soccer game suddenly fell forward. Dur-
ing the following months his legs were sore and his thighs 
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were swollen. CK was 22,000 U/L. He was hospitalized 6 
months later in a pediatric rheumathology unit.
A muscle biopsy showed diffuse macrophage infiltra-
tion, lymphocytic reaction, degenerative and regenerating 
muscle fibers, increased expression of MHC class I mol-
ecules. Muscle protein analysis by western blot showed 
normal dystrophin and alpha-sarcoglycan. These changes 
were interpreted as myositis.
A  treatment  with  Prednisone  50  mg/day  for  15 
months without response was performed. Thereafter, a 
treatment with azathioprine and cyclosporine were tried 
without response, IVIg were also added without clinical 
response and he was kept on steroids.
After  15  months  of  prednisone  he  developed  a 
Cushingoid appearance, buffalo hump, massive weight 
gain and osteoporosis.
Neurological examination showed waddling gait, dif-
ficulty raising from the floor, proximal muscle weakness 
(ileopsoas muscle 4/5, gluteus muscle 4/5, tibialis anterior 
muscle  4/5).  EMG  showed  small  polyphasic  potentials. 
Muscle  CT  scan  showed  diffuse  abnormality  of  proxi-
mal muscle in lower extremities. At age 17 years a sec-
ond muscle biopsy on vastus lateralis muscle showed few 
inflammatory  cells  that  appeared  secondary  to  necrosis 
as demonstrated by the predominance of macrophages in 
the infiltrate (Fig. 1). Dysferlin protein analysis by west-
ern blot showed absent dysferlin protein. The patient was 
therefore investigated for dysferlin gene mutations and two 
compound  heterozygote  mutations  were  identified:  one 
frame-shifting deletion in exon 23 (c.2200_2205delinsT, 
p.T734SfsX17) and one frame-shifting deletion in exon 32 
(c.3516_3517del, p.S1173X). This patient was therefore a 
compound heterozygote of a null mutation and a missense 
point mutation but the protein resulted absent.
Figure 1. Patient 1 (panel on the left) shows atrophic thighs and calves and difficulty raising arms. Muscle biopsy his-
topathology shows fibres undergoing degeneration and fibro-fatty replacement with trichrome stain. Dysferlin western 
blot shows absent protein (lane 2). Patient 2 (panel on the right) climbs stairs with rail support and presents straight 
leg, bent spine and Cushingoid appearance. First muscle biopsy shows some degenerating fibres with haematoxylin-
eosin stain, which are undergoing phagocytosis with acid phosphatase stain. Note lower extent of phagocytosis in the 
second biopsy. Dysferlin western blot analysis shows absent dysferlin protein (lane 2). Molecular diagnosis in LGMD2B
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When the LGMD2B diagnosis was established, ster-
oid  treatment  was  tapered  down  and  patient  benefited 
from weight loss and less fluid retention. He had to be 
supplemented with Ca++ and biphosphonate for abnormal 
bone densitometry, due to the long term steroid treatment. 
His CK levels decreased from 12,752 U/L to 7,785 U/L.
Discussion
A false diagnosis of polymyositis is frequent in LG-
MD2B (1). The clinicians must maintain a high index of 
suspicion in front of a steroid resistant polymyositis (2): 
prolonged steroid treatment associated with immunosup-
pressive drugs should be avoided in refractory polymyosi-
tis if diagnosis is uncertain, because of their many associ-
ated adverse side effects. It is possible that steroids were 
not only unsuccessful in these two cases but might have 
worsened their outcome. Both cases had subacute onset 
in early teens. The second case, an active soccer player at 
age 14, presented a sudden onset of weakness with high 
CK, myalgias, swollen legs, and his first muscle biopsy 
was mistaken for a myositis, but clinical progression and 
muscle CT appearance were peculiar. Muscle biopsy was 
studied by Western blotting that gave in both cases the 
diagnosis of dysferlin deficiency. The disease progression 
is highly variable and additional factors as muscle fatigue, 
extent of autophagy and strenuous physical activity, that 
produce different types of physical stress, could deter-
mine different muscle injury and recovery. In agreement 
with previous study (3) an inflammatory response is seen 
in most dysferlinopathy cases. Rawat et al. (4) supposed 
that not only immune cells but also muscle cells can par-
ticipate in inflammatory process. Attenuated and persist-
ent muscle regeneration and release of chemotactic agent 
might also play a role (4). The amount of regenerating fib-
ers in dysferlinopathy is high (5, 2) and may be similar to 
myositis. The exact nature of the trigger and the molecular 
pathways that initiate and perpetuate muscle fiber damage 
and dysfunction in LGMD2B is still unclear.
A reliable method for dysferlinopathy diagnosis is 
western blotting and subsequent genetic screening that 
yielded in our two cases both mutations in the dysferlin 
gene allowing a precise prognosis and genetic counsel-
ling. Although clinical diagnostic clues for dysferlin-
opathy diagnosis (6) have been developed the protein 
test remains a simple and inexpensive way to perform a 
rapid genetic diagnosis since all cases with absent pro-
tein were found subsequently to have pathogenic muta-
tions (7).
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